Injury and subsequent regeneration of muscles for activation of local innate immunity to facilitate the development and relapse of autoimmune myositis in C57BL/6 mice

Arthritis and Rheumatology

Volumn 67, Issue 4, 2015, Pages 1107-1116

  Kimura, Naoki ^a   Hirata, Shinya ^a   Miyasaka, Nobuyuki ^a   Kawahata, Kimito ^a   Kohsaka, Hitoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATE BUFFERED SALINE; PROTEIN C; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL ISOLATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; MACROPHAGE; MOUSE; MUSCLE CELL; MUSCLE INJURY; MUSCLE REGENERATION; MYOSITIS; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RELAPSE; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; EXPERIMENTAL CNS AUTOIMMUNE DISEASE; IMMUNOLOGY; METABOLISM; RECURRENT DISEASE; REGENERATION; SKELETAL MUSCLE;

ANIMALS; CYTOKINES; IMMUNITY, INNATE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; MYOSITIS; NERVOUS SYSTEM AUTOIMMUNE DISEASE, EXPERIMENTAL; RECURRENCE; REGENERATION;

EID: 84925711185     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39017     Document Type: Article

References (28)

1. Nagaraju K, Lundberg I,. Inflammatory diseases of muscle and other myopathies. In:, Firestein G, editor. Kelley's textbook of rheumatology. 8th ed. Philadelphia: Saunders Elsevier; 2009. p. 1353-80.
2. Goebels N, Michaelis D, Engelhardt M, Huber S, Bender A, Pongratz D, et al. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest 1996; 97: 2905-10.
3. Nishio J, Suzuki M, Miyasaka N, Kohsaka H,. Clonal biases of peripheral CD8 T cell repertoire directly reflect local inflammation in polymyositis. J Immunol 2001; 167: 4051-8.
4. Sugihara T, Okiyama N, Suzuki M, Kohyama K, Matsumoto Y, Miyasaka N, et al. Definitive engagement of cytotoxic CD8 T cells in C protein-induced myositis, a murine model of polymyositis. Arthritis Rheum 2010; 62: 3088-92.
5. Sugihara T, Sekine C, Nakae T, Kohyama K, Harigai M, Iwakura Y, et al. A new murine model to define the critical pathologic and therapeutic mediators of polymyositis. Arthritis Rheum 2007; 56: 1304-14.
6. Okiyama N, Sugihara T, Oida T, Ohata J, Yokozeki H, Miyasaka N, et al. T lymphocytes and muscle condition act like seeds and soil in a murine polymyositis model. Arthritis Rheum 2012; 64: 3741-9.
7. Christensen ML, Pachman LM, Schneiderman R, Patel DC, Friedman JM,. Prevalence of coxsackie B virus antibodies in patients with juvenile dermatomyositis. Arthritis Rheum 1986; 29: 1365-70.
8. Lyon MG, Bloch DA, Hollak B, Fries JF,. Predisposing factors in polymyositis-dermatomyositis: results of a nationwide survey. J Rheumatol 1989; 16: 1218-24.
9. Nakashima R, Imura Y, Kobayashi S, Yukawa N, Yoshifuji H, Nojima T, et al. The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology (Oxford) 2010; 49: 433-40.
10. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007; 204: 1057-69.
11. Segawa M, Fukada S, Yamamoto Y, Yahagi H, Kanematsu M, Sato M, et al. Suppression of macrophage functions impairs skeletal muscle regeneration with severe fibrosis. Exp Cell Res 2008; 314: 3232-44.
12. Griffin CA, Apponi LH, Long KK, Pavlath GK,. Chemokine expression and control of muscle cell migration during myogenesis. J Cell Sci 2010; 123: 3052-60.
13. Nonaka I, Takagi A, Ishiura S, Nakase H, Sugita H,. Pathophysiology of muscle fiber necrosis induced by bupivacaine hydrochloride (Marcaine). Acta Neuropathol 1983; 60: 167-74.
14. Vignaud A, Hourde C, Butler-Browne G, Ferry A,. Differential recovery of neuromuscular function after nerve/muscle injury induced by crude venom from Notechis scutatus, cardiotoxin from Naja atra and bupivacaine treatments in mice. Neurosci Res 2007; 58: 317-23.
15. Zador E, Mendler L, Takacs V, de Bleecker J, Wuytack F,. Regenerating soleus and extensor digitorum longus muscles of the rat show elevated levels of TNF-α and its receptors, TNFR-60 and TNFR-80. Muscle Nerve 2001; 24: 1058-67.
16. Warren GL, Hulderman T, Jensen N, McKinstry M, Mishra M, Luster MI, et al. Physiological role of tumor necrosis factor α in traumatic muscle injury. FASEB J 2002; 16: 1630-2.
17. Warren GL, O'Farrell L, Summan M, Hulderman T, Mishra D, Luster MI, et al. Role of CC chemokines in skeletal muscle functional restoration after injury. Am J Physiol Cell Physiol 2004; 286: C1031-6.
18. Mammen AL, Amato AA,. Statin myopathy: a review of recent progress. Curr Opin Rheumatol 2010; 22: 644-50.
19. Albayda J, Mammen AL,. Is statin-induced myositis part of the polymyositis disease spectrum? Curr Rheumatol Rep 2014; 16: 433.
20. Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR, et al. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 2011; 63: 713-21.
21. Groom JR, Luster AD,. CXCR3 in T cell function. Exp Cell Res 2011; 317: 620-31.
22. Nishimura M, Umehara H, Nakayama T, Yoneda O, Hieshima K, Kakizaki M, et al. Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol 2002; 168: 6173-80.
23. Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, van Damme J, et al. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 1995; 95: 1370-6.
24. Nagaraju K, Raben N, Merritt G, Loeffler L, Kirk K, Plotz P,. A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin Exp Immunol 1998; 113: 407-14.
25. De Bleecker JL, Engel AG,. Expression of cell adhesion molecules in inflammatory myopathies and Duchenne dystrophy. J Neuropathol Exp Neurol 1994; 53: 369-76.
26. Chen SE, Gerken E, Zhang Y, Zhan M, Mohan RK, Li AS, et al. Role of TNF-α signaling in regeneration of cardiotoxin-injured muscle. Am J Physiol Cell Physiol 2005; 289: C1179-87.
27. Lu H, Huang D, Ransohoff RM, Zhou L,. Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. FASEB J 2011; 25: 3344-55.
28. Liao H, Franck E, Freret M, Adriouch S, Baba-Amer Y, Authier FJ, et al. Myoinjury transiently activates muscle antigen-specific CD8+ T cells in lymph nodes in a mouse model. Arthritis Rheum 2012; 64: 3441-51.